Dr. Gawrieh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
550 University Blvd
Indianapolis, IN 46202Phone+1 317-944-5000Fax+1 317-278-6870
Summary
- Dr. Samer Gawrieh is a hepatologist in Indianapolis, IN and is affiliated with multiple hospitals in the area, including Richard L. Roudebush Veterans Affairs Medical Center, Indiana University Health University Hospital, and Indiana University Health North Hospital. He received his medical degree from University of Aleppo Faculty of Medicine and has been in practice since 2004. He specializes in hepatology & liver transplantation and is experienced in hepatology, non-alcoholic fatty liver disease, alcoholic liver disease, transplant hepatology, and hepatocellular carcinoma.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Transplant Hepatology, 2004 - 2004
- Medical College of Wisconsin Affiliated HospitalsFellowship, Gastroenterology, 2001 - 2004
- Cook County Health and Hospitals SystemResidency, Internal Medicine, 1998 - 2001
- University of Aleppo Faculty of MedicineClass of 1996
Certifications & Licensure
- IN State Medical License 2013 - 2025
- WI State Medical License 2001 - 2025
- IL State Medical License 1998 - 2001
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Best Doctors in America
Clinical Trials
- Vitamin E for NASH Treatment in HIV Infected Individuals Start of enrollment: 2019 Oct 01
- Trial of Anakinra (Plus Zinc) or Prednisone in Patients With Severe Alcoholic Hepatitis Start of enrollment: 2020 Jul 10
- Velacur by Sonic Incytes for Portal Hypertension Start of enrollment: 2021 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 30 citationsHepatic Gene Networks in Morbidly Obese Patients With Nonalcoholic Fatty Liver DiseaseSamer Gawrieh, Tesfaye M. Baye, Melanie A. Carless, James R. Wallace, Richard A. Komorowski
Obesity Surgery. 2010-05-16 - 451 citationsA multisociety Delphi consensus statement on new fatty liver disease nomenclature.Mary E Rinella, Jeffrey V Lazarus, Vlad Ratziu, Sven M Francque, Arun J Sanyal
Hepatology. 2023-12-01 - 898 citationsA multisociety Delphi consensus statement on new fatty liver disease nomenclature.Mary E Rinella, Jeffrey V Lazarus, Vlad Ratziu, Sven M Francque, Arun J Sanyal
Journal of Hepatology. 2023-12-01
Press Mentions
- Are You ‘Connecting the Dots’ with Patients During Alcohol Awareness Month?April 29th, 2023
- The Liver Meeting: Hepatitis in Children, NASH, ‘Alarming’ Disparities in MortalityDecember 3rd, 2022
- Prednisone Bests Anakinra, Zinc for 90-Day Survival in Severe Alcohol-Related HepatitisNovember 9th, 2022
- Join now to see all
Other Languages
- Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: